Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma: clinical features, experience in Uganda

S K Kyalwazi

    Antibiotics and Chemotherapy
    |January 1, 1981
    PubMed
    Summary

    Kaposi

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa.

    International journal of cancer·1992
    Same author

    Neopterin and alpha-interferon in patients affected by Kaposi's sarcoma from Africa.

    European journal of cancer & clinical oncology·1989
    Same author

    Cytogenetic study of a cell line of human penile cancer.

    Annales de genetique·1987
    Same author

    Role of cytomegalovirus in Kaposi's sarcoma.

    IARC scientific publications·1984
    Same author

    Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies.

    International journal of cancer·1981
    Same author

    Etiological implications on Kaposi's sarcoma.

    Antibiotics and chemotherapy·1981

    Area of Science:

    • Oncology
    • Immunology
    • Epidemiology

    Background:

    • Kaposi's sarcoma (KS) is a multifocal disease prevalent in Uganda, primarily affecting males.
    • KS presents with varied clinical manifestations, including skin, visceral, bone, and lymph node involvement.

    Purpose of the Study:

    • To describe the epidemiology and clinical spectrum of Kaposi's sarcoma in Uganda.
    • To correlate histological types with prognosis and treatment strategies.
    • To investigate the role of host immunological status in disease progression.

    Main Methods:

    • Retrospective analysis of Kaposi's sarcoma cases in Uganda.
    • Clinical and histological classification of lesions.
    • Correlation of clinical presentation, histology, and patient outcomes.

    Main Results:

    • Kaposi's sarcoma in Uganda shows a male predominance (13:1 ratio).
    • Disease presentation ranges from slow-progressing skin nodules to aggressive visceral, bone, and lymph node lesions.
    • Histological types correlate with prognosis, and disease progression is linked to diminished cellular immunity.

    Conclusions:

    • Kaposi's sarcoma in Uganda exhibits distinct epidemiological and clinical features.
    • Histological classification is crucial for prognosis and guiding treatment.
    • Immunological status is a key factor in the transition from benign to malignant forms of Kaposi's sarcoma.

    Related Experiment Videos